JP Morgan Chase’s LYRA THERAPEUTICS INC LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-27
| Closed | -$83 | – | 7746 |
|
|
2025
Q4 | $83 | Hold |
27
| – | – | ﹤0.01% | 7229 |
|
|
2025
Q3 | $178 | Sell |
27
-165
| -86% | -$1.21K | ﹤0.01% | 7126 |
|
|
2025
Q2 | $1.72K | Sell |
192
-934
| -83% | -$7.75K | ﹤0.01% | 6556 |
|
|
2025
Q1 | $7.11K | Sell |
1,126
-2,003
| -64% | -$18.7K | ﹤0.01% | 6373 |
|
|
2024
Q4 | $32.3K | Buy |
3,129
+1,934
| +162% | +$21.3K | ﹤0.01% | 6141 |
|
|
2024
Q3 | $15.4K | Buy |
1,195
+782
| +189% | +$11.5K | ﹤0.01% | 6291 |
|
|
2024
Q2 | $5.72K | Sell |
413
-1,775
| -81% | -$201K | ﹤0.01% | 6361 |
|
|
2024
Q1 | $680K | Buy |
2,188
+1,525
| +230% | +$406K | ﹤0.01% | 4605 |
|
|
2023
Q4 | $174K | Buy |
663
+662
| +66,200% | +$120K | ﹤0.01% | 5467 |
|
|
2023
Q3 | $133 | Hold |
1
| – | – | ﹤0.01% | 6886 |
|
|
2023
Q2 | $140 | Hold |
1
| – | – | ﹤0.01% | 6672 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7014 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6810 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6686 |
|
|
2022
Q2 | $0 | Sell |
1
-154
| -99% | -$41.9K | ﹤0.01% | 6704 |
|
|
2022
Q1 | $31K | Buy |
155
+138
| +812% | +$30.3K | ﹤0.01% | 5953 |
|
|
2021
Q4 | $4K | Buy |
17
+16
| +1,600% | +$5.14K | ﹤0.01% | 6442 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6661 |
|
|
2021
Q2 | $0 | Sell |
1
-2,947
| -100% | -$1.34M | ﹤0.01% | 6491 |
|
|
2021
Q1 | $1.71M | Sell |
2,948
-872
| -23% | -$545K | ﹤0.01% | 3832 |
|
|
2020
Q4 | $2.18M | Buy |
3,820
+3,782
| +9,953% | +$2.13M | ﹤0.01% | 3419 |
|
|
2020
Q3 | $22K | Sell |
38
-29
| -43% | -$18K | ﹤0.01% | 5125 |
|
|
2020
Q2 | $38K | Buy |
+67
| New | +$49K | ﹤0.01% | 4911 |
|
Other funds holding LYRA
JP Morgan Chase's LYRA Position: Q1 2026 in Review
JP Morgan Chase sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 27 shares — an estimated $83 sold.
JP Morgan Chase first reported a position in LYRA in Q2 2020 and held it in 23 quarters. The position peaked at $2.18M in Q4 2020. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.
- JP Morgan Chase reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
- JP Morgan Chase sold 27 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $83.
- JP Morgan Chase first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 23 quarters.
- JP Morgan Chase's LYRA THERAPEUTICS INC position peaked at $2.18M in Q4 2020.
- 1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.